Cellectis (CLLS) Misses Q1 EPS Views

Cellectis (NASDAQ: CLLS) reported Q1 EPS of (EUR0.84), EUR0.44 worse than the analyst estimate of (EUR0.40). Revenue for the quarter came in at EUR9.5 million versus the consensus estimate of EUR10.3 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Lowe's slashes full-year sales outlook amid DIY spending pressure
• FOMC minutes from July 28-29th meeting